TG Therapeutics Inc Annual Shareholders Meeting Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the TG Therapeutics 2020 Annual Meeting of Stockholders. I would now like to hand the conference to your speaker today, Sean Power, please go ahead, sir.
Good morning. I'm Sean Power, Chief Financial Officer of TG Therapeutics, and will be presiding over today's meeting. In light of public health concerns due to COVID-19, we are broadcasting our meeting via live webcast.
On behalf of our company, I want to welcome you to our 2020 Annual Meeting of Stockholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting.
Let me begin by introducing the directors of the company in attendance by means of remote communications. With us today are Michael Weiss, Laurence Charney, William Kennedy, Yann Echelard, Ken Hoberman, Daniel Hume and Dr. Sagar Lonial. Also virtually present here today is Michael Monahan of CohnReznick, our independent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |